DUCTAL CARCINOMA IN-SITU - ASSESSMENT OF NECROSIS AND NUCLEAR MORPHOLOGY AND THEIR ASSOCIATION WITH BIOLOGICAL MARKERS

被引:49
作者
BOBROW, LG
HAPPERFIELD, LC
GREGORY, WM
MILLIS, RR
机构
[1] ICRF Clinical Oncology Unit, Guy's Hospital, London
关键词
BREAST; DUCTAL CARCINOMA IN SITU; NUCLEAR MORPHOLOGY; NECROSIS; PROLIFERATION; PROGESTERONE RECEPTOR; P53; CERBB(2);
D O I
10.1002/path.1711760404
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
One hundred and five cases of pure ductal carcinoma in situ (DCIS) seen in the Guy's Hospital breast unit between 1975 and 1991 were reviewed. The presence and extent of necrosis and the degree of cytonuclear differentiation were assessed and the expression of p53 protein, cerbB(2) protein, progesterone receptor, and a proliferation antigen KiS1, all factors reported to be of prognostic significance in invasive ductal carcinoma, was evaluated using immunohistochemical methods. A strong correlation was seen between the presence and extent of necrosis and the degree of cytonuclear differentiation and between both these morphological criteria and the biological markers as well as between the individual markers. The presence of extensive necrosis was associated with lack of cytonuclear differentiation and both were associated with a high proliferation rate, the presence of cerbB(2) and p53 protein, and the absence of progesterone receptors. In cases with little or no necrosis, there was good nuclear differentiation and a strong correlation with the presence of progesterone receptor, absence of cerbB(2) and p53 protein, and a low rate of proliferation.
引用
收藏
页码:333 / 341
页数:9
相关论文
共 38 条
[1]   ASSOCIATION OF P53 PROTEIN EXPRESSION WITH TUMOR-CELL PROLIFERATION RATE AND CLINICAL OUTCOME IN NODE-NEGATIVE BREAST-CANCER [J].
ALLRED, DC ;
CLARK, GM ;
ELLEDGE, R ;
FUQUA, SAW ;
BROWN, RW ;
CHAMNESS, GC ;
OSBORNE, CK ;
MCGUIRE, WL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (03) :200-206
[2]   COMPARATIVE PATHOLOGY OF BREAST-CANCER IN A RANDOMIZED TRIAL OF SCREENING [J].
ANDERSON, TJ ;
LAMB, J ;
DONNAN, P ;
ALEXANDER, FE ;
HUGGINS, A ;
MUIR, BB ;
KIRKPATRICK, AE ;
CHETTY, U ;
HEPBURN, W ;
SMITH, A ;
PRESCOTT, RJ ;
FORREST, P .
BRITISH JOURNAL OF CANCER, 1991, 64 (01) :108-113
[3]  
ASHIKARI R, 1971, CANCER, V28, P1182, DOI 10.1002/1097-0142(1971)28:5<1182::AID-CNCR2820280515>3.0.CO
[4]  
2-H
[5]   STEROID-RECEPTORS, CELLULAR KINETICS, AND LYMPH-NODE STATUS AS PROGNOSTIC FACTORS IN BREAST-CANCER [J].
BENNER, SE ;
CLARK, GM ;
MCGUIRE, WL .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 296 (01) :59-66
[6]  
BOBROW LG, 1994, SEMIN DIAGN PATHOL, V11, P199
[7]   PATHOLOGICAL PROGNOSTIC FACTORS IN BREAST-CANCER .1. THE VALUE OF HISTOLOGICAL GRADE IN BREAST-CANCER - EXPERIENCE FROM A LARGE STUDY WITH LONG-TERM FOLLOW-UP [J].
ELSTON, CW ;
ELLIS, IO .
HISTOPATHOLOGY, 1991, 19 (05) :403-410
[8]   LUMPECTOMY COMPARED WITH LUMPECTOMY AND RADIATION-THERAPY FOR THE TREATMENT OF INTRADUCTAL BREAST-CANCER [J].
FISHER, B ;
COSTANTINO, J ;
REDMOND, C ;
FISHER, E ;
MARGOLESE, R ;
DIMITROV, N ;
WOLMARK, N ;
WICKERHAM, DL ;
DEUTSCH, M ;
ORE, L ;
MAMOUNAS, E ;
POLLER, W ;
KAVANAH, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1581-1586
[9]  
FISHER ER, 1986, CANCER-AM CANCER SOC, V57, P197, DOI 10.1002/1097-0142(19860115)57:2<197::AID-CNCR2820570203>3.0.CO
[10]  
2-N